These Places and Companies Lead the Way in Developing Vaccines
Moderna leads all companies in vaccine candidates on PhRMA’s list, followed by such companies as Pfizer, GSK and BioNTech.
Since 2000, according to Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. Food & Drug Administration (FDA) has approved nearly 900 new medicines, continuing a process that began in 1938 when President Franklin Delano Roosevelt signed the Food, Drug and Cosmetic Act. (A fascinating point of entry is provided by the FDA into the year-by-year data history of NDAs, which in this case stands for new drug applications.)
If 900 seems like a lot, a report released last week by PhRMA says even more about the accelerating pace of innovation, as it contains detailed information about 286 vaccines (31% of that 24-year total) in clinical development or awaiting FDA review. The report, which includes a potential first-in-class vaccine for E. coli and a potential therapeutic vaccine for Alzheimer’s disease, fills a 42-page PDF that’s hard to sort by criteria such as location and company. So we did it for you.
CSL Seqirus performs manufacturing at this complex in Holly Springs, North Carolina..
Photo courtesy of CSL Seqirus
Moderna Therapeutics, which early this month opened a new headquarters in Cambridge, Massachusetts, is the out-and-out leader in vaccine candidates with 33 medicines overall (including some with partners such as Merck), developed to treat such diseases as COVID variants, seasonal flu and Respiratory syncytial virus (RSV). Below are the tallies for the top sponsoring companies alongside their headquarters locations. (Forty-two of the 286 medicines involve multiple partners.)
Company
Vaccine Candidates
Headquarters
Moderna
33
Cambridge, Massachusetts
GSK
20
Philadelphia, Pennsylvania
Pfizer
19
New York, New York
BioNTech
14
Cambridge, Massachusetts
Sanofi
14
Bridgewater, New Jersey*
Inovio Pharmaceuticals
9
Plymouth Meeting, Pennsylvania
CSL Seqirus
6
Summit, New Jersey
Johnson & Johnson
6
Raritan, New Jersey
VBI Vaccines
6
Cambridge, Massachusetts
Vaxxinity
5
Merritt Island, Florida
Emergent BioSolutions
5
Gaithersburg, Maryland
Vaxart
5
South San Francisco, California
Gritstone bio
5
Emeryville, California
*Sanofi is moving 1,900 employees from Bridgewater to new digs in Morristown, New Jersey
Notably, 29 of the listings are connected to companies based abroad, including six in South Korea, five in France, four in Norway and three in China. Paris, Seoul and Oslo account for four apiece.
ADVERTISEMENT
If we award a point to geographic locations for every time they are mentioned in the list, here are the top U.S. states and cities:
State
Total Points
Massachusetts
70
California
48
New Jersey
39
New York
37
Pennsylvania
34
Maryland
21
Florida
9
Texas
6
North Carolina
5
City
Total Points
Cambridge, Massachusetts
61
New York, New York
28
Philadelphia, Pennsylvania
24
Bridgewater, New Jersey*
17
San Diego, California
11
Gaithersburg, Maryland
9
Plymouth Meeting, Pennsylvania
9
Boston, Massachusetts
8
Emeryville, California
8
South San Francisco, California
8
Rockville, Maryland
7
Summit, New Jersey
6
*see footnote above
Headquarters locations don’t tell the whole story. CSL Seqirus, for example, has its U.S. HQ in Summit, New Jersey, but major manufacturing takes place in Holly Springs, North Carolina, and the company maintains R&D operations in the same location nearly everyone else does: Cambridge, Massachusetts. — Adam Bruns
Data entry and organization for this report was performed by Karen Medernach, Daniel Boyer and McKenzie Wright.
This laboratory space at 325 Binney Street on the Alexandria Center® at One Kendall Square mega campus in Cambridge, Massachusetts, is part of Moderna’s newly opened HQ and R&D complex.
Photo courtesy of Alexandria Real Estate Equities, Inc.
Even as the all-Canada-made Project Arrow EV grabbed headlines with its debut early this year (see p. 32), a global Canadian automotive power continues to flex across the entire...
Government cutbacks spur site selectors to seek locations with strong balance sheets. A new era of fiscal austerity — from the federal level on down — is prompting site selection consultants to steer an increasing number of projects toward destinations that have their financial houses in order.
The National Institutes of Health made news this week when it announced it plans to substantially reduce the use of chimpanzees in NIH-funded biomedical research and designate for retirement most of the chimpanzees it currently owns or supports.
Paris-based healthcare and pharmaceutical giant Sanofi last month announced an expansion of its partnership with GDF SUEZ energy services subsidiary Cofely that will implement primarily renewable energy production and distribution systems worth up to €80 million at Sanofi industrial sites around the world over the next five years.
S wept up by the urge to bring capital investment back to their own shores, many U.S. state legislatures in 2004 have pursued laws to either discourage or ban use of offshore facilities and workers by companies engaged in state contracts. Many of those measures languish in committee. But while that raft of measures looks […]